ORMP
Oramed Pharmaceuticals Inc.Company with tickers: ORMP
CIK
1176309
CUSIP
68403P203
Shares Outstanding
40,926,081
Website
https://www.oramed.com
Investor Relations
https://oramed.com/investor-relations/
13F Activity (30d)
5 filings
4 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-K/A | 2025-07-16 | 2024-12-31 | |
| 8-K | 2025-07-23 | 2025-07-22 | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-08-21 | 2025-08-19 | |
| 8-K | 2025-10-06 | 2025-09-30 | |
| 8-K | 2025-10-24 | 2025-10-20 | |
| 10-Q | 2025-11-13 | 2025-09-30 | |
| 8-K | 2025-11-17 | — | |
| 8-K | 2025-11-17 | 2025-11-16 | |
| 8-K | 2025-12-31 | 2025-12-30 | |
| 8-K | 2025-12-31 | — | |
| 8-K | 2026-01-07 | — | |
| 8-K | 2026-01-14 | 2026-01-12 | |
| 8-K | 2026-02-20 | 2026-02-19 | |
| 10-K | 2026-03-26 | 2025-12-31 | |
| 8-K | 2026-03-31 | 2026-03-25 | |
| 10-Q | 2026-05-19 | 2026-03-31 |
Showing 101–117 of 117 filings